Anders Grubb (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anders Grubb" in English language version.

refsWebsite

Global rank English rank

28nih.gov

4^th place

24doi.org

2^nd place

12semanticscholar.org

11^th place

8^th place

1lu.se

4,012^th place

4,295^th place

1google.se

2,848^th place

low place

1orcid.org

low place

1tandfonline.com

507^th place

429^th place

1harvard.edu

18^th place

17^th place

1nature.com

234^th place

397^th place

1kireports.org

low place

doi.org

Löfberg, H.; Grubb, A. O. (1979). "Quantitation of γ-trace in human biological fluids: Indications for production in the central nervous system". Scandinavian Journal of Clinical and Laboratory Investigation. 39 (7): 619–626. doi:10.3109/00365517909108866. PMID 119302.
Grubb, A.; Löfberg, H. (1982). "Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis". Proceedings of the National Academy of Sciences of the United States of America. 79 (9): 3024–3027. Bibcode:1982PNAS...79.3024G. doi:10.1073/pnas.79.9.3024. PMC 346341. PMID 6283552.
Grubb, Anders; Löfberg, Helge; Barrett, Alan J. (May 21, 1984). "The disulphide bridges of human cystatin C (γ-trace) and chicken cystatin". FEBS Letters. 170 (2): 370–374. doi:10.1016/0014-5793(84)81346-0. S2CID 84217118 – via ScienceDirect.
Janowski, R.; Kozak, M.; Jankowska, E.; Grzonka, Z.; Grubb, A.; Abrahamson, M.; Jaskolski, M. (2001). "Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping". Nature Structural Biology. 8 (4): 316–320. doi:10.1038/86188. PMID 11276250. S2CID 28916747.
Abrahamson, M; Olafsson, I; Palsdottir, A; Ulvsbäck, M; Lundwall, Å; Jensson, O; Grubb, A (June 1, 1990). "Structure and expression of the human cystatin C gene". Biochemical Journal. 268 (2): 287–294. doi:10.1042/bj2680287. PMC 1131430. PMID 2363674 – via Silverchair.
Barrett, A. J.; Davies, M. E.; Grubb, A. (1984). "The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors". Biochemical and Biophysical Research Communications. 120 (2): 631–636. doi:10.1016/0006-291x(84)91302-0. PMID 6203523.
Björck, Lars; Åkesson, Per; Bohus, Martin; Trojnar, Jerzy; Abrahamson, Magnus; Olafsson, Isleifur; Grubb, Anders (January 24, 1989). "Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor". Nature. 337 (6205): 385–386. doi:10.1038/337385a0. PMID 2643059. S2CID 4267641 – via www.nature.com.
Grubb, A.; Jensson, O.; Gudmundsson, G.; Arnason, A.; Löfberg, H.; Malm, J. (1984). "Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis". The New England Journal of Medicine. 311 (24): 1547–1549. doi:10.1056/NEJM198412133112406. PMID 6390199.
Grubb, A.; Simonsen, O.; Sturfelt, G.; Truedsson, L.; Thysell, H. (1985). "Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate". Acta Medica Scandinavica. 218 (5): 499–503. doi:10.1111/j.0954-6820.1985.tb08880.x. PMID 3911736.
Kyhse-Andersen, J.; Schmidt, C.; Nordin, G.; Andersson, B.; Nilsson-Ehle, P.; Lindström, V.; Grubb, A. (1994). "Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate". Clinical Chemistry. 40 (10): 1921–1926. doi:10.1093/clinchem/40.10.1921. PMID 7923773.
Dharnidharka, V. R.; Kwon, C.; Stevens, G. (2002). "Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis". American Journal of Kidney Diseases. 40 (2): 221–226. doi:10.1053/ajkd.2002.34487. PMID 12148093.
Ottosson Frost, Carl; Gille-Johnson, Per; Blomstrand, Emanuel; St-Aubin, Viggo; Leion, Felicia; Grubb, Anders (February 2, 2022). "Cystatin C-based equations for estimating glomerular filtration rate do not require race or sex coefficients". Scandinavian Journal of Clinical and Laboratory Investigation. 82 (2): 162–166. doi:10.1080/00365513.2022.2031279. PMID 35107398. S2CID 246474625.
Grubb, A.; Blirup-Jensen, S.; Lindström, V.; Schmidt, C.; Althaus, H.; Zegers, I.; IFCC Working Group on Standardisation of Cystatin C (WG-SCC) (2010). "First certified reference material for cystatin C in human serum ERM-DA471/IFCC". Clinical Chemistry and Laboratory Medicine. 48 (11): 1619–1621. doi:10.1515/CCLM.2010.318. PMID 21034257. S2CID 27001585.
Christensson, A.; Ash, J. A.; Delisle, R. K.; Gaspar, F. W.; Ostroff, R.; Grubb, A.; Lindström, V.; Bruun, L.; Williams, S. A. (2018). "The Impact of the Glomerular Filtration Rate on the Human Plasma Proteome". Proteomics. Clinical Applications. 12 (3): e1700067. doi:10.1002/prca.201700067. PMID 29281176. S2CID 33866012.
Grubb, A. (2010). "Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check". Scandinavian Journal of Clinical and Laboratory Investigation. 70 (2): 65–70. doi:10.3109/00365511003642535. PMC 4673578. PMID 20170415.
Grubb, Anders; Lindström, Veronica; Jonsson, Magnus; Bäck, Sten-Erik; Åhlund, Tomas; Rippe, Bengt; Christensson, Anders (2015). "Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'". Scandinavian Journal of Clinical and Laboratory Investigation. 75 (4): 333–340. doi:10.3109/00365513.2015.1025427. PMC 4487590. PMID 25919022.
Zhou, H.; Yang, M.; He, X.; Xu, N. (2019). "eGFR, cystatin C and creatinine in shrunken pore syndrome". Clinica Chimica Acta; International Journal of Clinical Chemistry. 498: 1–5. doi:10.1016/j.cca.2019.08.001. PMID 31398310. S2CID 199518035.
Dardashti, Alain; Nozohoor, Shahab; Grubb, Anders; Bjursten, Henrik (December 9, 2015). "Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting". Scandinavian Journal of Clinical and Laboratory Investigation. 76 (1): 74–81. doi:10.3109/00365513.2015.1099724. PMC 4720044. PMID 26647957.
Herou, Erik; Dardashti, Alain; Nozohoor, Shahab; Zindovic, Igor; Ederoth, Per; Grubb, Anders; Bjursten, Henrik (2019). "The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C/eGFRcreatinine-ratio". Scandinavian Journal of Clinical and Laboratory Investigation. 79 (3): 167–173. doi:10.1080/00365513.2019.1576101. PMID 30767571. S2CID 73422769.
Almén, Markus Sällman; Björk, Jonas; Nyman, Ulf; Lindström, Veronica; Jonsson, Magnus; Abrahamson, Magnus; Vestergren, AnnaLotta Schiller; Lindhe, Örjan; Franklin, Gary; Christensson, Anders; Grubb, Anders (January 1, 2019). "Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins". Kidney International Reports. 4 (1): 67–79. doi:10.1016/j.ekir.2018.09.002. PMC 6308389. PMID 30596170. S2CID 57013450 – via www.kireports.org.
Xhakollari, L.; Jujic, A.; Molvin, J.; Nilsson, P.; Holm, H.; Bachus, E.; Leosdottir, M.; Grubb, A.; Christensson, A.; Magnusson, M. (2021). "Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients: Shrunken pore syndrome and proteomic associations". Proteomics. Clinical Applications. 15 (4): e2000089. doi:10.1002/prca.202000089. PMID 33682349. S2CID 232140448.
Åkesson, A.; Lindström, V.; Nyman, U.; Jonsson, M.; Abrahamson, M.; Christensson, A.; Björk, J.; Grubb, A. (2020). "Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities". Scandinavian Journal of Clinical and Laboratory Investigation. 80 (5): 412–422. doi:10.1080/00365513.2020.1759139. PMID 32459111. S2CID 218910266.
Grubb, Anders (September 24, 2020). "Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options". Clinical Biochemistry. 83: 12–20. doi:10.1016/j.clinbiochem.2020.06.002. PMID 32544475. S2CID 219726525.

dx.doi.org

Grubb, Anders; Löfberg, Helge; Barrett, Alan J. (May 21, 1984). "The disulphide bridges of human cystatin C (γ-trace) and chicken cystatin". FEBS Letters. 170 (2): 370–374. doi:10.1016/0014-5793(84)81346-0. S2CID 84217118 – via ScienceDirect.

google.se

scholar.google.se

"Anders Grubb". scholar.google.se.

harvard.edu

ui.adsabs.harvard.edu

Grubb, A.; Löfberg, H. (1982). "Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis". Proceedings of the National Academy of Sciences of the United States of America. 79 (9): 3024–3027. Bibcode:1982PNAS...79.3024G. doi:10.1073/pnas.79.9.3024. PMC 346341. PMID 6283552.

kireports.org

Almén, Markus Sällman; Björk, Jonas; Nyman, Ulf; Lindström, Veronica; Jonsson, Magnus; Abrahamson, Magnus; Vestergren, AnnaLotta Schiller; Lindhe, Örjan; Franklin, Gary; Christensson, Anders; Grubb, Anders (January 1, 2019). "Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins". Kidney International Reports. 4 (1): 67–79. doi:10.1016/j.ekir.2018.09.002. PMC 6308389. PMID 30596170. S2CID 57013450 – via www.kireports.org.

lu.se

portal.research.lu.se

"Anders Grubb". Lund University.

nature.com

Björck, Lars; Åkesson, Per; Bohus, Martin; Trojnar, Jerzy; Abrahamson, Magnus; Olafsson, Isleifur; Grubb, Anders (January 24, 1989). "Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor". Nature. 337 (6205): 385–386. doi:10.1038/337385a0. PMID 2643059. S2CID 4267641 – via www.nature.com.

nih.gov

pubmed.ncbi.nlm.nih.gov

Löfberg, H.; Grubb, A. O. (1979). "Quantitation of γ-trace in human biological fluids: Indications for production in the central nervous system". Scandinavian Journal of Clinical and Laboratory Investigation. 39 (7): 619–626. doi:10.3109/00365517909108866. PMID 119302.
Grubb, A.; Löfberg, H. (1982). "Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis". Proceedings of the National Academy of Sciences of the United States of America. 79 (9): 3024–3027. Bibcode:1982PNAS...79.3024G. doi:10.1073/pnas.79.9.3024. PMC 346341. PMID 6283552.
Janowski, R.; Kozak, M.; Jankowska, E.; Grzonka, Z.; Grubb, A.; Abrahamson, M.; Jaskolski, M. (2001). "Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping". Nature Structural Biology. 8 (4): 316–320. doi:10.1038/86188. PMID 11276250. S2CID 28916747.
Abrahamson, M; Olafsson, I; Palsdottir, A; Ulvsbäck, M; Lundwall, Å; Jensson, O; Grubb, A (June 1, 1990). "Structure and expression of the human cystatin C gene". Biochemical Journal. 268 (2): 287–294. doi:10.1042/bj2680287. PMC 1131430. PMID 2363674 – via Silverchair.
Barrett, A. J.; Davies, M. E.; Grubb, A. (1984). "The place of human gamma-trace (cystatin C) amongst the cysteine proteinase inhibitors". Biochemical and Biophysical Research Communications. 120 (2): 631–636. doi:10.1016/0006-291x(84)91302-0. PMID 6203523.
Björck, Lars; Åkesson, Per; Bohus, Martin; Trojnar, Jerzy; Abrahamson, Magnus; Olafsson, Isleifur; Grubb, Anders (January 24, 1989). "Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor". Nature. 337 (6205): 385–386. doi:10.1038/337385a0. PMID 2643059. S2CID 4267641 – via www.nature.com.
Grubb, A.; Jensson, O.; Gudmundsson, G.; Arnason, A.; Löfberg, H.; Malm, J. (1984). "Abnormal metabolism of gamma-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis". The New England Journal of Medicine. 311 (24): 1547–1549. doi:10.1056/NEJM198412133112406. PMID 6390199.
Grubb, A.; Simonsen, O.; Sturfelt, G.; Truedsson, L.; Thysell, H. (1985). "Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate". Acta Medica Scandinavica. 218 (5): 499–503. doi:10.1111/j.0954-6820.1985.tb08880.x. PMID 3911736.
Kyhse-Andersen, J.; Schmidt, C.; Nordin, G.; Andersson, B.; Nilsson-Ehle, P.; Lindström, V.; Grubb, A. (1994). "Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate". Clinical Chemistry. 40 (10): 1921–1926. doi:10.1093/clinchem/40.10.1921. PMID 7923773.
Dharnidharka, V. R.; Kwon, C.; Stevens, G. (2002). "Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis". American Journal of Kidney Diseases. 40 (2): 221–226. doi:10.1053/ajkd.2002.34487. PMID 12148093.
Ottosson Frost, Carl; Gille-Johnson, Per; Blomstrand, Emanuel; St-Aubin, Viggo; Leion, Felicia; Grubb, Anders (February 2, 2022). "Cystatin C-based equations for estimating glomerular filtration rate do not require race or sex coefficients". Scandinavian Journal of Clinical and Laboratory Investigation. 82 (2): 162–166. doi:10.1080/00365513.2022.2031279. PMID 35107398. S2CID 246474625.
Grubb, A.; Blirup-Jensen, S.; Lindström, V.; Schmidt, C.; Althaus, H.; Zegers, I.; IFCC Working Group on Standardisation of Cystatin C (WG-SCC) (2010). "First certified reference material for cystatin C in human serum ERM-DA471/IFCC". Clinical Chemistry and Laboratory Medicine. 48 (11): 1619–1621. doi:10.1515/CCLM.2010.318. PMID 21034257. S2CID 27001585.
Christensson, A.; Ash, J. A.; Delisle, R. K.; Gaspar, F. W.; Ostroff, R.; Grubb, A.; Lindström, V.; Bruun, L.; Williams, S. A. (2018). "The Impact of the Glomerular Filtration Rate on the Human Plasma Proteome". Proteomics. Clinical Applications. 12 (3): e1700067. doi:10.1002/prca.201700067. PMID 29281176. S2CID 33866012.
Grubb, A. (2010). "Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check". Scandinavian Journal of Clinical and Laboratory Investigation. 70 (2): 65–70. doi:10.3109/00365511003642535. PMC 4673578. PMID 20170415.
Grubb, Anders; Lindström, Veronica; Jonsson, Magnus; Bäck, Sten-Erik; Åhlund, Tomas; Rippe, Bengt; Christensson, Anders (2015). "Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'". Scandinavian Journal of Clinical and Laboratory Investigation. 75 (4): 333–340. doi:10.3109/00365513.2015.1025427. PMC 4487590. PMID 25919022.
Zhou, H.; Yang, M.; He, X.; Xu, N. (2019). "eGFR, cystatin C and creatinine in shrunken pore syndrome". Clinica Chimica Acta; International Journal of Clinical Chemistry. 498: 1–5. doi:10.1016/j.cca.2019.08.001. PMID 31398310. S2CID 199518035.
Dardashti, Alain; Nozohoor, Shahab; Grubb, Anders; Bjursten, Henrik (December 9, 2015). "Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting". Scandinavian Journal of Clinical and Laboratory Investigation. 76 (1): 74–81. doi:10.3109/00365513.2015.1099724. PMC 4720044. PMID 26647957.
Herou, Erik; Dardashti, Alain; Nozohoor, Shahab; Zindovic, Igor; Ederoth, Per; Grubb, Anders; Bjursten, Henrik (2019). "The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C/eGFRcreatinine-ratio". Scandinavian Journal of Clinical and Laboratory Investigation. 79 (3): 167–173. doi:10.1080/00365513.2019.1576101. PMID 30767571. S2CID 73422769.
Almén, Markus Sällman; Björk, Jonas; Nyman, Ulf; Lindström, Veronica; Jonsson, Magnus; Abrahamson, Magnus; Vestergren, AnnaLotta Schiller; Lindhe, Örjan; Franklin, Gary; Christensson, Anders; Grubb, Anders (January 1, 2019). "Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins". Kidney International Reports. 4 (1): 67–79. doi:10.1016/j.ekir.2018.09.002. PMC 6308389. PMID 30596170. S2CID 57013450 – via www.kireports.org.
Xhakollari, L.; Jujic, A.; Molvin, J.; Nilsson, P.; Holm, H.; Bachus, E.; Leosdottir, M.; Grubb, A.; Christensson, A.; Magnusson, M. (2021). "Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients: Shrunken pore syndrome and proteomic associations". Proteomics. Clinical Applications. 15 (4): e2000089. doi:10.1002/prca.202000089. PMID 33682349. S2CID 232140448.
Åkesson, A.; Lindström, V.; Nyman, U.; Jonsson, M.; Abrahamson, M.; Christensson, A.; Björk, J.; Grubb, A. (2020). "Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities". Scandinavian Journal of Clinical and Laboratory Investigation. 80 (5): 412–422. doi:10.1080/00365513.2020.1759139. PMID 32459111. S2CID 218910266.
Grubb, Anders (September 24, 2020). "Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options". Clinical Biochemistry. 83: 12–20. doi:10.1016/j.clinbiochem.2020.06.002. PMID 32544475. S2CID 219726525.

ncbi.nlm.nih.gov

Grubb, A.; Löfberg, H. (1982). "Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis". Proceedings of the National Academy of Sciences of the United States of America. 79 (9): 3024–3027. Bibcode:1982PNAS...79.3024G. doi:10.1073/pnas.79.9.3024. PMC 346341. PMID 6283552.
Abrahamson, M; Olafsson, I; Palsdottir, A; Ulvsbäck, M; Lundwall, Å; Jensson, O; Grubb, A (June 1, 1990). "Structure and expression of the human cystatin C gene". Biochemical Journal. 268 (2): 287–294. doi:10.1042/bj2680287. PMC 1131430. PMID 2363674 – via Silverchair.
Grubb, A. (2010). "Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: Simultaneous use of cystatin C- and creatinine-based GFR-prediction equations, clinical data and an internal quality check". Scandinavian Journal of Clinical and Laboratory Investigation. 70 (2): 65–70. doi:10.3109/00365511003642535. PMC 4673578. PMID 20170415.
Grubb, Anders; Lindström, Veronica; Jonsson, Magnus; Bäck, Sten-Erik; Åhlund, Tomas; Rippe, Bengt; Christensson, Anders (2015). "Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'". Scandinavian Journal of Clinical and Laboratory Investigation. 75 (4): 333–340. doi:10.3109/00365513.2015.1025427. PMC 4487590. PMID 25919022.
Dardashti, Alain; Nozohoor, Shahab; Grubb, Anders; Bjursten, Henrik (December 9, 2015). "Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting". Scandinavian Journal of Clinical and Laboratory Investigation. 76 (1): 74–81. doi:10.3109/00365513.2015.1099724. PMC 4720044. PMID 26647957.
Almén, Markus Sällman; Björk, Jonas; Nyman, Ulf; Lindström, Veronica; Jonsson, Magnus; Abrahamson, Magnus; Vestergren, AnnaLotta Schiller; Lindhe, Örjan; Franklin, Gary; Christensson, Anders; Grubb, Anders (January 1, 2019). "Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins". Kidney International Reports. 4 (1): 67–79. doi:10.1016/j.ekir.2018.09.002. PMC 6308389. PMID 30596170. S2CID 57013450 – via www.kireports.org.

orcid.org

"ORCID". orcid.org.

semanticscholar.org

api.semanticscholar.org

Grubb, Anders; Löfberg, Helge; Barrett, Alan J. (May 21, 1984). "The disulphide bridges of human cystatin C (γ-trace) and chicken cystatin". FEBS Letters. 170 (2): 370–374. doi:10.1016/0014-5793(84)81346-0. S2CID 84217118 – via ScienceDirect.
Janowski, R.; Kozak, M.; Jankowska, E.; Grzonka, Z.; Grubb, A.; Abrahamson, M.; Jaskolski, M. (2001). "Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping". Nature Structural Biology. 8 (4): 316–320. doi:10.1038/86188. PMID 11276250. S2CID 28916747.
Björck, Lars; Åkesson, Per; Bohus, Martin; Trojnar, Jerzy; Abrahamson, Magnus; Olafsson, Isleifur; Grubb, Anders (January 24, 1989). "Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor". Nature. 337 (6205): 385–386. doi:10.1038/337385a0. PMID 2643059. S2CID 4267641 – via www.nature.com.
Ottosson Frost, Carl; Gille-Johnson, Per; Blomstrand, Emanuel; St-Aubin, Viggo; Leion, Felicia; Grubb, Anders (February 2, 2022). "Cystatin C-based equations for estimating glomerular filtration rate do not require race or sex coefficients". Scandinavian Journal of Clinical and Laboratory Investigation. 82 (2): 162–166. doi:10.1080/00365513.2022.2031279. PMID 35107398. S2CID 246474625.
Grubb, A.; Blirup-Jensen, S.; Lindström, V.; Schmidt, C.; Althaus, H.; Zegers, I.; IFCC Working Group on Standardisation of Cystatin C (WG-SCC) (2010). "First certified reference material for cystatin C in human serum ERM-DA471/IFCC". Clinical Chemistry and Laboratory Medicine. 48 (11): 1619–1621. doi:10.1515/CCLM.2010.318. PMID 21034257. S2CID 27001585.
Christensson, A.; Ash, J. A.; Delisle, R. K.; Gaspar, F. W.; Ostroff, R.; Grubb, A.; Lindström, V.; Bruun, L.; Williams, S. A. (2018). "The Impact of the Glomerular Filtration Rate on the Human Plasma Proteome". Proteomics. Clinical Applications. 12 (3): e1700067. doi:10.1002/prca.201700067. PMID 29281176. S2CID 33866012.
Zhou, H.; Yang, M.; He, X.; Xu, N. (2019). "eGFR, cystatin C and creatinine in shrunken pore syndrome". Clinica Chimica Acta; International Journal of Clinical Chemistry. 498: 1–5. doi:10.1016/j.cca.2019.08.001. PMID 31398310. S2CID 199518035.
Herou, Erik; Dardashti, Alain; Nozohoor, Shahab; Zindovic, Igor; Ederoth, Per; Grubb, Anders; Bjursten, Henrik (2019). "The mortality increase in cardiac surgery patients associated with shrunken pore syndrome correlates with the eGFRcystatin C/eGFRcreatinine-ratio". Scandinavian Journal of Clinical and Laboratory Investigation. 79 (3): 167–173. doi:10.1080/00365513.2019.1576101. PMID 30767571. S2CID 73422769.
Almén, Markus Sällman; Björk, Jonas; Nyman, Ulf; Lindström, Veronica; Jonsson, Magnus; Abrahamson, Magnus; Vestergren, AnnaLotta Schiller; Lindhe, Örjan; Franklin, Gary; Christensson, Anders; Grubb, Anders (January 1, 2019). "Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins". Kidney International Reports. 4 (1): 67–79. doi:10.1016/j.ekir.2018.09.002. PMC 6308389. PMID 30596170. S2CID 57013450 – via www.kireports.org.
Xhakollari, L.; Jujic, A.; Molvin, J.; Nilsson, P.; Holm, H.; Bachus, E.; Leosdottir, M.; Grubb, A.; Christensson, A.; Magnusson, M. (2021). "Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients: Shrunken pore syndrome and proteomic associations". Proteomics. Clinical Applications. 15 (4): e2000089. doi:10.1002/prca.202000089. PMID 33682349. S2CID 232140448.
Åkesson, A.; Lindström, V.; Nyman, U.; Jonsson, M.; Abrahamson, M.; Christensson, A.; Björk, J.; Grubb, A. (2020). "Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities". Scandinavian Journal of Clinical and Laboratory Investigation. 80 (5): 412–422. doi:10.1080/00365513.2020.1759139. PMID 32459111. S2CID 218910266.
Grubb, Anders (September 24, 2020). "Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options". Clinical Biochemistry. 83: 12–20. doi:10.1016/j.clinbiochem.2020.06.002. PMID 32544475. S2CID 219726525.

tandfonline.com

Löfberg, H.; Grubb, A. O. (1979). "Quantitation of γ-trace in human biological fluids: Indications for production in the central nervous system". Scandinavian Journal of Clinical and Laboratory Investigation. 39 (7): 619–626. doi:10.3109/00365517909108866. PMID 119302.